Literature DB >> 34446355

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report - 2021; Focus on recipient characteristics.

Daniel C Chambers1, Michael Perch1, Andreas Zuckermann1, Wida S Cherikh1, Michael O Harhay1, Don Hayes1, Eileen Hsich1, Kiran K Khush1, Luciano Potena1, Aparna Sadavarte1, Kelsi Lindblad1, Tajinder P Singh1, Josef Stehlik2.   

Abstract

For over 30 years, the International Society for Heart and Lung Transplantation (ISHLT) International Thoracic Organ Transplant (TTX) Registry has gathered data regarding transplant procedures, donor and recipient characteristics, and outcomes from a global community of transplant centers. Almost 70,000 adult lung transplant procedures have been reported to the Registry since its inception, each one providing an opportunity for a recipient with end-stage lung disease to regain quality of life and longevity. With each year's report, we provide more detailed analyses on a particular focus theme important to recipient outcomes. Since 2013, these have been donor and recipient age; retransplantation; early graft failure; indication for transplant; allograft ischemic time; multiorgan transplantation; and donor and recipient size matching.1-7 In response to a changing regulatory environment, the ISHLT TTX Registry is undergoing an update in data acquisition, and the patient cohort examined in this report is therefore derived from the same data source or datasets as that examined in the 2019 annual reports.2,8-10 We refer the reader to the 2019 and prior reports for a detailed description of the baseline characteristics of the cohort, and additional core analyses not directly related to the focus explored in this year's report. To complement the 2020 report which focussed on donor characteristics, the goal of this year's report was to focus entirely on changes in recipient factors over the past 3 decades and to identify important recipient characteristics and transplant processes that may influence post-transplant outcomes. Due to small numbers, heart-lung transplant recipient characteristics and transplant outcomes have not been included. This 38th annual adult lung transplant report is hence based on data submitted to the ISHLT TTX Registry on 67,493 adult recipients of deceased recipient transplants between January 1, 1992 and June 30, 2018. Published by Elsevier Inc.

Entities:  

Keywords:  lung transplantation; morbidity; post-transplant survival; recipient characteristics; registry

Mesh:

Year:  2021        PMID: 34446355     DOI: 10.1016/j.healun.2021.07.021

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  11 in total

1.  [COVID-19 after heart transplantation: experiences from a German transplantation center].

Authors:  Daniel Oehler; Raphael Romano Bruno; Hans Torulv Holst; Igor Tudorache; Hug Aubin; Dennis Sigetti; Patrick Horn; Payam Akhyari; Malte Kelm; Artur Lichtenberg; Ralf Westenfeld; Udo Boeken
Journal:  Z Herz Thorax Gefasschir       Date:  2022-07-20

2.  The Predictive Role of Intraoperative Blood Transfusion Components in the Prognosis of Heart Transplantation.

Authors:  Yidan Zheng; Li Xu; Ziwen Cai; Jingrong Tu; Yuqi Liu; Yixuan Wang; Si Chen; Nianguo Dong; Fei Li
Journal:  Front Cardiovasc Med       Date:  2022-05-20

3.  Effect of 2D and 3D Culture Microenvironments on Mesenchymal Stem Cell-Derived Extracellular Vesicles Potencies.

Authors:  Gina D Kusuma; Anqi Li; Dandan Zhu; Hannah McDonald; Ishmael M Inocencio; Daniel C Chambers; Kenneth Sinclair; Haoyun Fang; David W Greening; Jessica E Frith; Rebecca Lim
Journal:  Front Cell Dev Biol       Date:  2022-02-14

Review 4.  Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates.

Authors:  Shun Kawashima; Kole Joachim; Maen Abdelrahim; Ala Abudayyeh; Kenar D Jhaveri; Naoka Murakami
Journal:  Korean J Transplant       Date:  2022-06-03

5.  Impact of Extracorporeal Membrane Oxygenation on Right Ventricular Function After Heart Transplantation.

Authors:  Cheng Zhao; Xing Hao; Chao Xue; Yichen Zhao; Jie Han; Yixin Jia; Xiaotong Hou; Jiangang Wang
Journal:  Front Cardiovasc Med       Date:  2022-07-15

Review 6.  Manipulating Cardiomyocyte Plasticity for Heart Regeneration.

Authors:  Toshiyuki Ko; Seitaro Nomura
Journal:  Front Cell Dev Biol       Date:  2022-07-11

Review 7.  Why Cell-Free DNA Can Be a "Game Changer" for Lung Allograft Monitoring for Rejection and Infection.

Authors:  J P Rosenheck; B C Keller; G Fehringer; Z P Demko; S M Bohrade; D J Ross
Journal:  Curr Pulmonol Rep       Date:  2022-07-26

8.  Indications for Lung Transplantation and Patient Selection.

Authors:  Joohyung Son; Changwon Shin
Journal:  J Chest Surg       Date:  2022-08-05

9.  Diabetes Is an Independent Risk Factor for Cancer after Heart and/or Lung Transplantation.

Authors:  Hristo Kirov; Alexandros Moschovas; Tulio Caldonazo; Imke Schwan; Gloria Faerber; Tim Sandhaus; Thomas Lehmann; Torsten Doenst
Journal:  J Clin Med       Date:  2022-07-15       Impact factor: 4.964

10.  Lung Transplantation for Patients with COVID-19 Acute Respiratory Distress Syndrome.

Authors:  Woo Hyun Cho
Journal:  J Chest Surg       Date:  2022-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.